|
Medina P, Navarro S, Corral J, Zorio E, Roldán V, Estellés A, Santamaría A, Marín F, Rueda J, Bertina RM, España F; RECAVA Thrombosis Groups. Endothelial protein C receptor polymorphisms and risk of myocardial infarction. Haematologica. 2008 Sep;93(9):1358-63. doi: 10.3324/haematol.13066. PubMed PMID: 18757851.
AÑO: 2008; IF: 5.978
|
18757851
|
Pastor-Pérez FJ, Marín F, Manzano-Fernández S, Lip GY. Is thrombogenesis related to residual platelet function in ischaemic heart disease? Eur Heart J. 2008 Dec;29(24):3065; author reply 3065-6. doi: 10.1093/eurheartj/ehn472. Epub 2008 Oct 25. PubMed PMID: 18953049.
AÑO: 2008; IF: 8.917
|
|
Roldán V, Marín F. Contra: 'Antithrombotic therapy with warfarin, aspirin and clopidogrel is the recommended regimen in anticoagulated patients who present with an acute coronary syndrome and/or undergo percutaneous coronary interventions'. Not for everybody. Thromb Haemost. 2008 Nov;100(5):754-5. PubMed PMID: 18989516.
AÑO: 2008; IF: 3.803
|
|
Manzano-Fernández S, Marín F, Pastor-Pérez FJ, Caro C, Cambronero F, Lacunza J, Pinar E, Pascual-Figal DA, Valdés M, Lip GY. Impact of chronic kidney disease on major bleeding complications and mortality in patients with indication for oral anticoagulation undergoing coronary stenting. Chest. 2009 Apr;135(4):983-90. doi: 10.1378/chest.08-1425. Epub 2008 Nov 18. PubMed PMID: 19017872.
AÑO: 2009; IF: 6.36
|
|
Navarro-Núñez L, Roldán V, Lozano ML, Rivera J, Marin F, Vicente V, Martínez C. TUBB1 Q43P polymorphism does not protect against acute coronary syndrome and premature myocardial infarction. Thromb Haemost. 2008 Dec;100(6):1211-3. PubMed PMID: 19132255.
AÑO: 2008; IF: 3.803
|